J. B. Chemicals & Pharmaceuticals Limited
JBCHEPHARM
Rang in Aktien
#3892
J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai,... J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai, India, in 1976, specializes in the development, production, and global distribution of diverse pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. Among its prominent product offerings are Cilnidipine, Ranitidine, and Metronidazole. Beyond its own brands, the company extends comprehensive contract manufacturing services, covering an extensive spectrum of dosage forms such as tablets, various lozenge types, injectables, gels, creams, ointments, liquid herbal syrups, and capsules. The firm further contributes to diagnostic medicine by supplying contrast agents for advanced imaging techniques like X-ray, MRI, and ultrasound. Its therapeutic expertise encompasses a broad range of medical fields, including gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance.
Aktienkurs
$26.58
Zuletzt synchronisiert: 2026-07-23
Marktkapitalisierung
$4.24B
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
38.14%
Land
IN
Handel J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
Kategorie
Healthcare
P/B-Verhältnis für J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
P/B-Verhältnis zum October 2026 TTM: 9.27
Laut den neuesten Finanzberichten und dem Aktienkurs von J. B. Chemicals & Pharmaceuticals Limited beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 9.27. Am Ende des Jahres 2024 lag das P/B-Verhältnis bei 8.99.
P/B-Verlauf für J. B. Chemicals & Pharmaceuticals Limited von 2005 bis 2026
P/B-Verhältnis zum Jahresende
| Jahr | P/B-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 9.27 | 29.34% |
| 2025 | 7.17 | -20.26% |
| 2024 | 8.99 | 45.87% |
| 2023 | 6.16 | 7.98% |
| 2022 | 5.71 | 6.43% |
| 2021 | 5.36 | 91.96% |
| 2020 | 2.79 | 36.00% |
| 2019 | 2.05 | 12.86% |
| 2018 | 1.82 | -15.48% |
| 2017 | 2.15 | 11.29% |
| 2016 | 1.93 | 13.81% |
| 2015 | 1.70 | 63.33% |
| 2014 | 1.04 | 64.51% |
| 2013 | 0.63 | 18.87% |
| 2012 | 0.53 | -67.05% |
| 2011 | 1.62 | 53.39% |
| 2010 | 1.05 | 60.86% |
| 2009 | 0.65 | -29.39% |
| 2008 | 0.93 | -41.37% |
| 2007 | 1.58 | -43.38% |
| 2006 | 2.79 | 19.52% |
| 2005 | 2.34 | 0.00% |
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/B-Verhältnis | P/B-Verhältnis-Differenz | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -45.64% |
IN
|
